Integrin inhibitor, BMS-688521, Purity ≥98%

Synonym: 893397-44-9; BMS688521; BMS 688521; 6-[(5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl]pyridine-3-carboxylic acid

CAS Number: 893397-44-9
Compound CID: 11699447

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

MSDS

Properties

Description

BMS-688521 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.

Molecular Weight

536.37

Molecular Formula

C₂₆H₁₉Cl₂N₅O₄

Form

Lyophilized powder

Purity

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Applications

BMS-688521 is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis by blocking the interaction of integrin α4β7 with its ligands in the gut.